Loading data
FICONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.99 bn USD | 1.72 bn USD | 1.51 bn USD | 1.38 bn USD |
| Cost of revenue | 353.72 m USD | 348.21 m USD | 311.05 m USD | 302.17 m USD |
| Research and development expense | 188.35 m USD | 171.94 m USD | 159.95 m USD | 146.76 m USD |
| Selling, general and administrative expense | 513.03 m USD | 462.83 m USD | 400.57 m USD | 383.86 m USD |
| Operating profit | 924.85 m USD | 733.63 m USD | 642.83 m USD | 542.41 m USD |
| Interest expense | — | 105.64 m USD | 95.55 m USD | 68.97 m USD |
| Profit before tax | 802.6 m USD | 642.03 m USD | 553.62 m USD | 471.31 m USD |
| Income tax expense | 150.65 m USD | 129.21 m USD | 124.25 m USD | 97.77 m USD |
| Net income (reported basis) | 651.9 m USD | 512.8 m USD | 429.4 m USD | 373.5 m USD |
| Basic earnings per share | 26.9 USD/share | 20.78 USD/share | 17.18 USD/share | 14.34 USD/share |
| Diluted earnings per share | 26.54 USD/share | 20.45 USD/share | 16.93 USD/share | 14.18 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.